Castañeda Ruiz Angel J, Shetab Boushehri Maryam A, Phan Tamara, Carle Stefan, Garidel Patrick, Buske Julia, Lamprecht Alf
Department of Pharmaceutical Technology and Biopharmaceutics, University of Bonn, 53121 Bonn, Germany.
Boehringer Ingelheim Pharma GmbH & Co. KG, Innovation Unit, PDB, Birkendorfer Straße 65, 88397 Biberach an der Riss, Germany.
Pharmaceutics. 2022 Nov 23;14(12):2575. doi: 10.3390/pharmaceutics14122575.
Given their safety and efficiency in protecting protein integrity, polysorbates (PSs) have been the most widely used excipients for the stabilization of protein therapeutics for years. In recent decades, however, there have been numerous reports about visible or sub-visible particles in PS-containing biotherapeutic products, which is a major quality concern for parenteral drugs. Alternative excipients that are safe for parenteral administration, efficient in protecting different protein drugs against various stress conditions, effective in protein stabilization in high-concentrated liquid formulations, stable under the storage conditions for the duration of the product's shelf-life, and compatible with other formulation components and the primary packaging are highly sought after. The aim of this paper is to review potential alternative excipients from different families, including surfactants, carbohydrate- and amino acid-based excipients, synthetic amphiphilic polymers, and ionic liquids that enable protein stabilization. For each category, important characteristics such as the ability to stabilize proteins against thermal and mechanical stresses, current knowledge related to the safety profile for parenteral administration, potential interactions with other formulation components, and primary packaging are debated. Based on the provided information and the detailed discussion thereof, this paper may pave the way for the identification or development of efficient excipients for biotherapeutic protein stabilization.
鉴于聚山梨酯(PSs)在保护蛋白质完整性方面的安全性和有效性,多年来它一直是用于稳定蛋白质治疗药物的最广泛使用的辅料。然而,近几十年来,有许多关于含PS的生物治疗产品中出现可见或亚可见颗粒的报道,这是注射用药物的一个主要质量问题。人们迫切需要替代辅料,这些辅料应具有适合注射给药的安全性,能有效保护不同的蛋白质药物免受各种应激条件的影响,在高浓度液体制剂中能有效稳定蛋白质,在产品保质期内的储存条件下稳定,并且与其他制剂成分和内包装兼容。本文的目的是综述来自不同类别(包括表面活性剂、基于碳水化合物和氨基酸的辅料、合成两亲聚合物和离子液体)的潜在替代辅料,这些辅料能够实现蛋白质的稳定化。对于每一类,都会讨论一些重要特性,如稳定蛋白质抵抗热和机械应力的能力、目前关于注射给药安全性的知识、与其他制剂成分的潜在相互作用以及与内包装的关系。基于所提供的信息及其详细讨论,本文可能为鉴定或开发用于稳定生物治疗蛋白质的高效辅料铺平道路。